NDC codes

FDA NDC Directory
Product NDC (as listed)71335-9688Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71335-9688Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71335-9688-17133596880130 TABLET, FILM COATED in 1 BOTTLE (71335-9688-1)Marketed from Apr 3, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Vardenafil Hydrochloride
Generic name (nonproprietary)
vardenafil hydrochloride
Active ingredients
Vardenafil hydrochloride20 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 091347
Marketing start
Listing expires
Other FDA classes
Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers
Product ID 71335-9688_5b030c96-c5e2-4cde-abda-d6eedff4169dSPL ID 5b030c96-c5e2-4cde-abda-d6eedff4169dSPL set ID 31be68b0-ac7e-42d0-9435-1f0a329b63d8RxCUI 349480UNII 5M8S2CU0TS
Pharmacologic class
Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335968801 followed by a unit qualifier and the quantity

Package 71335-9688-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Vardenafil hydrochloride tablets are indicated for the treatment of erectile dysfunction. Vardenafil hydrochloride tablets are a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091347

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091347
ProductStrengthForm · routeLabelerProduct NDC
Vardenafil HydrochlorideVardenafil hydrochloride 10 mg/1Tablet, Film coatedOralTeva Pharmaceuticals USA, Inc.0093-7654
Vardenafil HydrochlorideVardenafil hydrochloride 2.5 mg/1Tablet, Film coatedOralTeva Pharmaceuticals USA, Inc.0093-7652
Vardenafil HydrochlorideVardenafil hydrochloride 5 mg/1Tablet, Film coatedOralTeva Pharmaceuticals USA, Inc.0093-7653
Vardenafil HydrochlorideVardenafil hydrochloride 20 mg/1Tablet, Film coatedOralTeva Pharmaceuticals USA, Inc.0093-7655

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in